Catriona Duncan

2.0k total citations
27 papers, 555 citations indexed

About

Catriona Duncan is a scholar working on Ophthalmology, Molecular Biology and Genetics. According to data from OpenAlex, Catriona Duncan has authored 27 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Catriona Duncan's work include Ocular Oncology and Treatments (16 papers), Glioma Diagnosis and Treatment (6 papers) and Glaucoma and retinal disorders (5 papers). Catriona Duncan is often cited by papers focused on Ocular Oncology and Treatments (16 papers), Glioma Diagnosis and Treatment (6 papers) and Glaucoma and retinal disorders (5 papers). Catriona Duncan collaborates with scholars based in United Kingdom, United States and Israel. Catriona Duncan's co-authors include Mandeep S. Sagoo, M. Ashwin Reddy, Tanzina Chowdhury, Ido Didi Fabian, Zerrin Onadim, Esin Kotiloğlu Karaa, Irene Scheimberg, Shin‐ichi Ohnuma, Francisco Bautista and S. Ashley and has published in prestigious journals such as Oncogene, Ophthalmology and British Journal of Cancer.

In The Last Decade

Catriona Duncan

26 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catriona Duncan United Kingdom 11 265 143 102 94 92 27 555
A Topham United States 7 355 1.3× 110 0.8× 25 0.2× 99 1.1× 192 2.1× 9 633
Annemarie Klingenstein Germany 14 282 1.1× 70 0.5× 77 0.8× 85 0.9× 60 0.7× 40 481
Sameh E. Soliman Egypt 12 903 3.4× 147 1.0× 59 0.6× 144 1.5× 194 2.1× 33 992
Diane Rushlow Canada 9 176 0.7× 153 1.1× 44 0.4× 35 0.4× 172 1.9× 11 496
S Khorana United States 11 250 0.9× 184 1.3× 48 0.5× 154 1.6× 49 0.5× 12 639
Lauris Gastaud France 12 107 0.4× 64 0.4× 25 0.2× 47 0.5× 74 0.8× 36 395
Craig A. Portell United States 16 38 0.1× 154 1.1× 118 1.2× 14 0.1× 50 0.5× 65 765
K. Adams United Kingdom 6 121 0.5× 56 0.4× 57 0.6× 31 0.3× 28 0.3× 8 520
Omshree Shetty India 12 22 0.1× 171 1.2× 30 0.3× 31 0.3× 224 2.4× 83 559
P. Mukhopadhyay United States 9 42 0.2× 47 0.3× 20 0.2× 85 0.9× 136 1.5× 27 658

Countries citing papers authored by Catriona Duncan

Since Specialization
Citations

This map shows the geographic impact of Catriona Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catriona Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catriona Duncan more than expected).

Fields of papers citing papers by Catriona Duncan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catriona Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catriona Duncan. The network helps show where Catriona Duncan may publish in the future.

Co-authorship network of co-authors of Catriona Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of Catriona Duncan. A scholar is included among the top collaborators of Catriona Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catriona Duncan. Catriona Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Löbel, Ulrike, Sniya Sudhakar, Asthik Biswas, et al.. (2024). Pineal gland ADC values in children aged 0 to 4 years: normative data and usefulness in the differential diagnosis with trilateral retinoblastoma. Neuroradiology. 66(12). 2291–2299. 1 indexed citations
3.
Duncan, Catriona, et al.. (2024). Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom. British Journal of Cancer. 131(3). 491–497. 1 indexed citations
4.
Duncan, Catriona, Arnauld Verschuur, Beatriz de Camargo, et al.. (2023). Impact of the COVID‐19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group study. Cancer Medicine. 12(16). 17098–17111. 4 indexed citations
5.
Hol, Janna A., Kelly Vallance, Harm van Tinteren, et al.. (2022). Pediatric renal tumor epidemiology: Global perspectives, progress, and challenges. Pediatric Blood & Cancer. 70(1). e30006–e30006. 8 indexed citations
6.
Karaa, Esin Kotiloğlu, Tanzina Chowdhury, Irene Scheimberg, et al.. (2022). Systemic adjuvant chemotherapy for advanced malignant ocular medulloepithelioma. Eye. 37(5). 947–952. 3 indexed citations
7.
Kratz, Christian P., Marjolijn C.J. Jongmans, Hélène Cavé, et al.. (2021). Predisposition to cancer in children and adolescents. The Lancet Child & Adolescent Health. 5(2). 142–154. 63 indexed citations
8.
Pritchard‐Jones, Kathy, Jesper Brok, William Mifsud, et al.. (2021). Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant. Pediatric Nephrology. 37(4). 821–832. 9 indexed citations
9.
Duncan, Catriona, et al.. (2020). Sclero-conjunctival ischaemia secondary to intra-arterial chemotherapy for retinoblastoma. American Journal of Ophthalmology Case Reports. 18. 100611–100611. 2 indexed citations
10.
Fabian, Ido Didi, Noa Kapelushnik, Zerrin Onadim, et al.. (2020). Number, frequency and time interval of examinations under anesthesia in bilateral retinoblastoma. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(4). 879–886. 4 indexed citations
11.
Reddy, M. Ashwin, et al.. (2020). Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic). Ophthalmology Retina. 5(4). 381–387. 6 indexed citations
12.
Fabian, Ido Didi, Zerrin Onadim, Esin Kotiloğlu Karaa, et al.. (2018). The management of retinoblastoma. Oncogene. 37(12). 1551–1560. 180 indexed citations
13.
Fabian, Ido Didi, Andrew W. Stacey, Tanzina Chowdhury, et al.. (2017). Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes. American Journal of Ophthalmology. 179. 137–144. 23 indexed citations
14.
Fabian, Ido Didi, Andrew W. Stacey, Kenneth C. Johnson, et al.. (2017). Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye. British Journal of Ophthalmology. 102(2). 265–271. 18 indexed citations
15.
Reddy, M. Ashwin, Catriona Duncan, Fergus Robertson, et al.. (2017). Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma. British Journal of Ophthalmology. 101(12). 1704–1708. 21 indexed citations
16.
Fabian, Ido Didi, Andrew W. Stacey, Kenneth P. Johnson, et al.. (2016). Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis. British Journal of Ophthalmology. 101(1). 82–88. 30 indexed citations
17.
Duncan, Catriona. (2011). Highlights from the Sixth International Symposium on Diabetes and Pregnancy. The British Journal of Diabetes. 11(6). 319–320. 1 indexed citations
18.
Moreno, Lucas, Francisco Bautista, S. Ashley, Catriona Duncan, & Stergios Zacharoulis. (2010). Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence. European Journal of Cancer. 46(12). 2253–2259. 72 indexed citations
19.
Duncan, Catriona, et al.. (2006). Determinants of International Acquisition Success:. European Management Journal. 24(6). 396–410. 29 indexed citations
20.
Duncan, Catriona, et al.. (2004). Stevens–Johnson syndrome with visceral arteritis due to sulphonylurea therapy. Practical Diabetes International. 21(5). 195–198. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Topham Breakdown of academic impact, for papers by Annemarie Klingenstein Breakdown of academic impact, for papers by Sameh E. Soliman Breakdown of academic impact, for papers by Diane Rushlow Breakdown of academic impact, for papers by S Khorana Breakdown of academic impact, for papers by Lauris Gastaud Breakdown of academic impact, for papers by Craig A. Portell Breakdown of academic impact, for papers by K. Adams Breakdown of academic impact, for papers by Omshree Shetty Breakdown of academic impact, for papers by P. Mukhopadhyay
Rankless by CCL
2026